Wave Life Sciences
WVE
3.42
-0.13
-3.53%
Wave Life Sciences
US · WVE
#3515 by market cap
Listed 2015
3.42
-0.13
-3.53%
Live - 5344 symbols - heartbeat 348s ago
· 2026-10-08 09:59
Pre-market
3.51
-0.82%
After-hours
3.54
-0.06%
- Market cap
- 672.92M
- P/E (TTM)i
- -3.16
- P/Bi
- 1.48
- EPSi
- -1.21
- Div yieldi
- 0.00%
- 52W posi
- 0%
Reader sentiment
Are you bullish or bearish on WVE?
Anonymous reader poll. Unscientific, not investment advice.
About Wave Life Sciences
Wave Life Sciences Ltd. is a clinical-stage biotechnology company, which focuses on developing its proprietary RNA medicines platform and PRISM. It develops and commercializes a pipeline of RNA medicines across a variety of therapeutic areas. The company was founded by Gregory L. Verdine and Takeshi Wada on July 23, 2012 and is headquartered in Singapore.
- Founded
- 2012
- CEO
- Dr. Paul B. Bolno, M.B.A.,M.D.
- Employees
- 317
- Headquarters
- Singapore, Central Singapore, Singapore
- Fiscal year end
- 12-31
- Website
- wavelifesciences.com
Company profile
- Exchange
- US
- Symbol
- WVE
- Market-cap rank
- #3515
- Listing date
- 2015-11-11
- Market cap
- 672.92M
- Float cap
- 322.97M
- Shares out
- 197.05M
- Float shares
- 94.57M
Sectors & themes
Quote time 2026-10-08 09:59:47 · For reference only, not investment advice and not tailored to your situation.